Corbus Pharmaceuticals Holdings (CRBP) Assets Average (2014 - 2025)

Corbus Pharmaceuticals Holdings' Assets Average history runs 12 years deep, the most recent figure standing at $138.9 million for Q4 2025.

• On a quarterly basis, Assets Average fell 13.23% year-over-year to $138.9 million in Q4 2025; TTM through Dec 2025 was $138.9 million, a 13.23% decrease from a year earlier, with the FY2025 full-year figure at $162.0 million, up 75.98% from the prior year.
• Assets Average improved to $138.9 million in Q4 2025 per CRBP's latest filing, from $117.3 million in the prior quarter.
• Across five years, Assets Average topped out at $160.0 million in Q4 2024 and bottomed at $32.3 million in Q4 2023.
• The 5-year median for Assets Average is $115.5 million (2021), against an average of $103.7 million.
• Across the five-year window, Assets Average plunged 53.94% in 2023 and soared 395.78% in 2024, its largest moves.
• Year by year, Assets Average stood at $113.7 million in 2021, then sank by 38.35% to $70.1 million in 2022, then tumbled by 53.94% to $32.3 million in 2023, then surged by 395.78% to $160.0 million in 2024, then fell by 13.23% to $138.9 million in 2025.
• Per Business Quant, the three latest CRBP Assets Average figures stand at $138.9 million (Q4 2025), $117.3 million (Q3 2025), and $132.5 million (Q2 2025).